MATAWAN, N.J. & EUGENE, Ore., October 14, 2025--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE: APUS) ("Apimeds") today announced the expansion of the Apimeds ai ² Futures Lab program through ...
MATAWAN, N.J. & MOSCOW, Idaho, November 10, 2025--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) ("Apimeds") today announced the expansion of its ai² Futures Lab™ program ...